This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Ketamine/Propofol vs Ketamine Alone for Pediatric Fracture Reduction

This study has been completed.
University of Western Ontario, Canada
Information provided by:
Lawson Health Research Institute Identifier:
First received: June 21, 2007
Last updated: August 14, 2008
Last verified: August 2008
The objective of this study is to compare Ketamine-Propofol with Ketamine-only in a double-blind, randomised, controlled trial in a paediatric emergency department. We believe that the combination of these two agents will provide a new and more effective option for procedural sedation in paediatric emergency department patients. The hypothesis of the study is that paediatric emergency department patients requiring procedural sedation for an isolated orthopaedic injury with Ketamine-Propofol will have reduced time to recovery, complications and improved satisfaction scores compared to patients receiving Ketamine alone.

Condition Intervention Phase
Fractures Drug: Ketamine only Drug: Ketamine - Propofol Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Prospective Randomized Double Blind Evaluation of Ketamine/Propofol vs Ketamine Alone for Pediatric Extremity Fracture Reduction

Resource links provided by NLM:

Further study details as provided by Lawson Health Research Institute:

Primary Outcome Measures:
  • recovery time [ Time Frame: time that the last study drug was injected until the patient is fully recovered with a minimum recovery score ≥ 8 ]

Secondary Outcome Measures:
  • time from first drug to procedure start [ Time Frame: during and immediately after sedation ]
  • time from first drug injected to patient recovery [ Time Frame: during and immediately after sedation ]
  • patient, nurse, and physician satisfaction [ Time Frame: during and immediately after sedation ]
  • complications and adverse events [ Time Frame: during and immediately after sedation ]

Enrollment: 140
Study Start Date: June 2007
Study Completion Date: August 2008
Primary Completion Date: August 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: 1
Ketamine only arm
Drug: Ketamine only

Ketamine 1.0 mg/kg IV and placebo intralipid as initial sedation agents (double blinded).

Ketamine .25 mg/kg IV and placebo intralipid q2 minutes prn for additional sedation

Active Comparator: 2
Ketamine-Propofol arm
Drug: Ketamine - Propofol

Ketamine .5 mg/kg and Propofol 1 mg/kg as initial sedation agents (double-blinded).

Saline Placebo and Propofol .5 mg/kg q 2minutes for additional sedation

  Show Detailed Description


Ages Eligible for Study:   2 Years to 16 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Healthy pediatric emergency patients with isolated extremity injury requiring reduction

Exclusion Criteria:

  • Active respiratory illness
  • Seizure disorder
  • Craniofacial abnormalities
  • Allergy to soy, ketamine, or propofol
  • Hypertension
  • Significant renal, cardiovascular or neurologic disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00490997

Canada, Ontario
Children's Hospital of Western Ontario
London, Ontario, Canada, N6H 5B8
Sponsors and Collaborators
Lawson Health Research Institute
University of Western Ontario, Canada
Principal Investigator: Amit P Shah, MD FCFP(EM) University of Western Ontario, Canada
Principal Investigator: Greg Mosdossy, MD, FRCPC University of Western Ontario, Canada
Principal Investigator: Michael J Rieder, MD PhD FRCPC University of Western Ontario, Canada
  More Information

Responsible Party: Dr. Amit Shah, Division of Emergency Medicine, University of Western Ontario Identifier: NCT00490997     History of Changes
Other Study ID Numbers: R-07-017
IRF 044-06
Study First Received: June 21, 2007
Last Updated: August 14, 2008

Keywords provided by Lawson Health Research Institute:
emergency department

Additional relevant MeSH terms:
Fractures, Bone
Wounds and Injuries
Hypnotics and Sedatives
Central Nervous System Depressants
Physiological Effects of Drugs
Anesthetics, Intravenous
Anesthetics, General
Sensory System Agents
Peripheral Nervous System Agents
Anesthetics, Dissociative
Excitatory Amino Acid Antagonists
Excitatory Amino Acid Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action processed this record on July 26, 2017